Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postpartum Hemorrhage Reduction With Oral Tranexamic Acid (PROTECT): a Multicenter Randomized Controlled Trial

NCT06025916 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06025916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postpartum Hemorrhage Reduction With Oral Tranexamic Acid (PROTECT): a Multicenter Randomized Controlled Trial
Lead sponsor
Karolinska Institutet
Phase
Phase 4
Overall status
Recruiting
Start date
September 27, 2023
Completion date
March 31, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pph